|
시장보고서
상품코드
1877394
세계의 백신 관리 솔루션 시장 : 용도별, 유형별, 솔루션 유형별, 배포 모드별, 최종 사용자별, 백신 유형별, 국가별, 지역별 - 산업 분석, 규모, 점유율 및 예측(2025-2032년)Vaccine Management Solution Market, By Application, By Type, By Solution Type, By Deployment mode, By End-user, By Vaccine Type, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032 |
||||||
백신 관리 솔루션 시장 규모는 2024년 25억 7,845만 달러로 평가되었으며, 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 13.2%를 나타낼 전망입니다.
백신 관리 솔루션은 백신 관리 및 투여 프로세스를 단순화하는 디지털 플랫폼입니다. 백신 관리 솔루션은 의료 제공업체가 백신 재고 수준, 복용량, 만료 날짜, 보관 상태를 추적하는 데 도움이 됩니다. 이러한 솔루션은 주 정부와 지방 정부가 안전하고 신속하게 예방 접종을 수행하는 데 기여합니다. 여러 기업이 이 솔루션을 활용하여 직원의 예방접종 상황을 추적하고 있습니다. 백신으로 예방할 수 있는 질병의 세계적인 확산 확대에 따라 신뢰할 수 있는 백신 관리 시스템이 요구되고 있습니다. 정부가 주도하는 백신 접종 캠페인과 디지털 의료 인프라에 대한 투자가 시장 성장을 이끌고 있습니다. 그러나, 엄격한 백신 보관·유통 규제가 시장 진출기업의 과제가 되고 있습니다. 첨단 인프라와 높은 의료 지출로 북미 시장 침투율이 가장 높아지고 있습니다. 백신 연구 개발의 급속한 진전, 생산 능력 증진, 빈번한 규제 당국의 승인으로 미국은 계속해서 세계의 백신 관리 솔루션 시장을 주도하고 있습니다.
백신 관리 솔루션 시장 역학
세계 예방접종 프로그램 확대로 시장 성장 촉진
각국 및 세계 예방접종 프로그램의 급속한 확대는 백신 관리 솔루션 시장의 중요한 촉진요인입니다. 정부와 보건기구는 효율적인 유통, 실시간 추적 및 백신에 대한 공정한 액세스를 보장하기 위해 디지털 백신 관리 플랫폼으로의 전환을 가속화하고 있습니다. 이러한 솔루션은 콜드체인 물류 모니터링, 폐기물 감소, 백신 공급 시스템 투명성 향상에 기여합니다. 예를 들어 세계보건기구(WHO)의 추계에 따르면 2023년까지 세계의 백신접종률은 84%에 달했으며 다양한 예방접종 프로그램을 통해 44억 명 이상이 적어도 1회의 백신접종을 받을 전망입니다. 예방접종 이니셔티브의 규모가 확대됨에 따라 첨단 디지털 관리 시스템에 대한 수요가 증가하고 있으며, 의료기관과 정부는 업무 최적화 및 공급 무결성을 보장하기 위해 자동화된 클라우드 기반 백신 관리 솔루션에 대한 투자를 촉진하고 있습니다.
백신 관리 솔루션 시장 : 세분화 분석
세계의 백신 관리 솔루션 시장은 용도, 유형, 솔루션 유형, 배포 방식, 최종 사용자, 백신 유형 및 지역에 따라 구분됩니다.
솔루션 유형은 플랫폼 솔루션과 원포인트 솔루션의 두 가지 유형입니다. 2025년에는 플랫폼 솔루션 부문이 큰 시장 점유율을 차지할 전망입니다. 이 부문의 성장은 COVID-19 백신의 유통을 지원하기 위해 주요 시장 기업 간의 협력 강화에 기인합니다. 예를 들어, 2020년 11월에는 인포시스 리미티드와 소프트웨어 개발 회사 Sales Force가 제휴하여 Sales Force 플랫폼을 기반으로 한 백신 관리 클라우드 솔루션을 개발했습니다.
솔루션 유형별 : On-Premise 배포는 강력한 데이터 관리, 사용자 지정 유연성, 기관의 보안 프로토콜 준수를 통해 백신 관리 솔루션 시장에서 가장 선호되는 모델입니다. On-Premise 시스템은 엄격한 규제 프레임워크를 준수해야 하는 민감한 환자 기록 및 예방접종 기록을 관리하기 위해 병원, 정부 기관 및 제약 회사에서 자주 사용됩니다. 예를 들어, 2022년 10월에 몰디브에서는 일본의 독자적인 DHIS2 인프라를 기반으로 세계보건기구의 지원을 받아 전국 규모의 전자예방접종등록시스템(EIR)을 도입했습니다. 시스템을 내부적으로 호스팅함으로써 보건부는 데이터 액세스, 저장 및 보안 설정에 대한 완전한 관리 권한을 유지했습니다. 이러한 사례는 특히 데이터 주권을 선호하는 지역과 클라우드 인프라가 제한된 지역에서 On-Premise 솔루션이 여전히 주류인 이유를 돋보이게 합니다.
백신 관리 솔루션 시장 - 지역별 분석
2023년 북미는 세계의 백신 관리 솔루션 시장에서 큰 점유율을 차지했습니다. 간염, 결핵, 인유두종 바이러스(HPV) 등 다양한 질병의 만연을 억제하기 위한 백신접종 캠페인의 필요성이 높아지고 있는 것이, 이 지역의 성장을 견인하고 있습니다. 예를 들어 미국 국립생물공학정보센터(NCBI)가 2023년 3월 발표한 연구에 따르면 2022년 미국에서 보고된 결핵증례 수는 8,300건에 달했습니다. 또한, 백신접종과 공급망 관리를 지원하는 백신 관리 솔루션의 도입 증가가 시장 확대를 견인할 것으로 전망됩니다.
미국의 백신 관리 솔루션 시장 : 국가별 분석
미국은 백신 연구개발의 급속한 진전, 생산능력 증진, 빈번한 규제 당국의 승인을 통해 세계의 백신 관리 솔루션 시장에서 계속 큰 수익을 창출하고 있습니다. 특히 인플루엔자 백신 및 소아용 백신과 같은 백신 제제의 양이 증가함에 따라 재고 추적, 유통 및 콜드체인 모니터링을 위한 효율적인 디지털 플랫폼이 필요합니다. 예를 들어, 2022년 6월에 CSL Seqirus는 미국 시설을 1억 5,600만 달러로 확장하여 세포 배양 인플루엔자 백신의 제형 및 충전 및 마무리 능력을 향상시켰습니다. 또한 2021년 10월에는 미국 식품의약국(FDA)이 Seqirus사의 'FLUCELVAX QUADRIVALENT'의 적용 연령 범위 확대를 승인했습니다. 이러한 발전으로 백신 생산량과 유통의 복잡성이 증가하고 국내 전체에서 선진적인 백신 관리 솔루션의 도입이 가속화되고 있습니다.
백신 관리 솔루션 시장 : 경쟁 구도
IBM, Oracle Corporation, SAP SE, Infosys Limited, Microsoft Corporation, Deloitte Touche Tohmatsu Limited 등이 백신 관리 솔루션 시장의 주요 기업입니다. 이러한 기업들은 클라우드 컴퓨팅, 블록체인, AI를 활용한 분석 기술을 활용하여 백신의 유통, 보관, 추적 효율을 향상시키고 있습니다. IoT 지원 콜드체인 모니터링 시스템과 데이터 기반 재고 관리 플랫폼의 활용은 백신 공급 체인 전체에서 투명성과 실시간 가시성을 보장합니다. 기술 공급자, 의료 조직 및 정부 기관 간의 전략적 협력은 시장 성장 동향에 영향을 미칩니다. 세계 예방접종 프로그램이 확대되고 디지털 건강 인프라가 개선됨에 따라 경쟁 구도는 효율적이고 신뢰할 수 있는 백신 관리 솔루션에 대한 수요 증가에 대응하기 위해 데이터 보안, 확장성 및 상호 운용성의 혁신을 특징으로 합니다.
목차
제1장 백신 관리 솔루션 시장 개요
- 분석 범위
- 시장 추정 기간
제2장 주요 요약
- 시장 분석
- 경쟁 인사이트
제3장 백신 관리 솔루션의 주요 시장 동향
- 시장 성장 촉진요인
- 시장 성장 억제요인
- 시장 기회
- 시장 전망 동향
제4장 백신 관리 솔루션 시장 : 산업 분석
- PEST 분석
- Porter's Five Forces 분석
- 시장 성장 전망 : 매핑
- 규제 체제의 분석
제5장 백신 관리 솔루션 시장 : 높아지는 지정학적 긴장의 영향
- COVID-19 팬데믹의 영향
- 러시아·우크라이나 전쟁의 영향
- 중동 분쟁의 영향
제6장 백신 관리 솔루션 시장 상황
- 백신 관리 솔루션 시장 점유율 분석(2024년)
- 주요 제조업체별 분석 데이터
- 기존 기업의 분석
- 신흥 기업의 분석
제7장 백신 관리 솔루션 시장 : 용도별
- 개요
- 부문별 점유율 분석 : 용도별
- 공급망 관리
- 재고 관리
- 행정 및 기록 관리
- 결과 모니터링
- 조직 지원
- 환자 등록 및 예약
- 기타
제8장 백신 관리 솔루션 시장 : 유형별
- 개요
- 부문별 점유율 분석 : 유형별
- 플랫폼 솔루션
- 원포인트 솔루션
제9장 백신 관리 솔루션 시장 : 솔루션 유형별
- 개요
- 부문별 점유율 분석 : 솔루션 유형별
- On-Premise
- 클라우드 기반
- 하이브리드
제10장 백신 관리 솔루션 시장 : 배포 모드별
- 개요
- 부문별 점유율 분석 : 배포 모드별
- SaaS
- IaaS
- PaaS
- 자체 호스팅
제11장 백신 관리 솔루션 시장 : 최종 사용자별
- 개요
- 부문별 점유율 분석 : 최종 사용자별
- 병원 및 클리닉
- 정부 기관
- 기업 조직
- 기타
제12장 백신 관리 솔루션 시장 : 백신 유형별
- 개요
- 부문별 점유율 분석 : 백신 유형별
- 생백신
- 불활성화 백신
- 복합 백신
- 독소이드 백신
- 서브유닛 백신
제13장 백신 관리 솔루션 시장 : 지역별
- 서론
- 북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
- 유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
- 아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
- 라틴아메리카(LATAM)
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
- 중동 및 아프리카(MEA)
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타
제14장 주요 벤더 분석 : 백신 관리 솔루션 업계
- 경쟁 대시보드
- 경쟁 벤치마킹
- 경쟁 포지셔닝
- 기업 프로파일
- IBM Corporation
- Siemens Healthineers
- Accenture
- SAP SE
- Oracle Corporation
- Infosys Limited
- SoftClinic
- Logistimo Technologies
- OmniSYS
- VaxCare Digital Health
- Helix Software
- Blue Vector
- Andor Health
- STChealth
- eHealth Africa
- Others
제15장 AnalystView의 전방위 분석
KTHVaccine Management Solution Market size was valued at US$ 2,578.45 Million in 2024, expanding at a CAGR of 13.2% from 2025 to 2032.
Vaccine management solutions are digital platforms that simplify the process of managing and administering vaccines. Vaccine management solutions help healthcare providers track vaccine inventory levels, dose availability, expiration dates, and storage conditions. These solutions help state and local governments administer vaccinations safely and quickly. Several companies use this solution to track employee vaccinations. The increasing global prevalence of vaccine-preventable diseases requires reliable vaccine management systems. Government vaccination campaigns and digital health infrastructure investments are driving market growth. However, strict vaccine storage and distribution regulations challenge market participants. Market penetration is highest in North America due to advanced infrastructure and higher healthcare spending. Due to rapid vaccine R&D, increased production capacity, and frequent regulatory approvals, the US continues to dominate the global Vaccine Management Solution Market.
Vaccine Management Solution Market- Market Dynamics
Growing Global Immunization Programs to Boost Market Growth
The rapid expansion of national and global immunization programs is a significant driver of the Vaccine Management Solution Market. Governments and health organizations are increasingly turning to digital vaccine management platforms to ensure efficient distribution, real-time tracking, and equitable access to vaccines. These solutions help to monitor cold chain logistics, reduce waste, and improve vaccine delivery system transparency. For instance, the World Health Organization (WHO) estimates that global vaccination coverage will reach 84% by 2023, with over 4.4 billion people receiving at least one vaccine dose through various immunization programs. The growing scale of vaccination initiatives has increased the demand for advanced digital management systems, encouraging healthcare providers and governments to invest in automated, cloud-based vaccine management solutions to optimise operations and ensure supply integrity.
Vaccine Management Solution Market- Segmentation Analysis:
The Global Vaccine Management Solution Market is segmented on the basis of Application, Type, Solution Type, Deployment mode, End-user, Vaccine Type, and Region.
Platform solutions and one-point solutions are the two types. In 2025, the platform solutions segment holds a significant market share. The segment's growth is attributed to increased collaborations among key market players to support the distribution of COVID-19 vaccines. For example, in November 2020, Infosys Limited and Salesforce, a software development company, collaborated to develop a vaccine management cloud solution based on the Salesforce platform to assist the federal government in the distribution of coronavirus vaccines.
Based on Solution type: On-premise deployment remains the most preferred model in the vaccine management solution market due to its strong data control, customization flexibility, and compliance with institutional security protocols. On-premise systems are frequently used by hospitals, government agencies, and pharmaceutical companies to manage sensitive patient and immunization records that must adhere to strict regulatory frameworks. For instance, in October 2022, the Maldives will launch its nationwide Electronic Immunization Registry (EIR), based on the country's own DHIS2 infrastructure and with World Health Organization support. By hosting the system internally, the Ministry of Health retained complete control over data access, storage, and security settings. Such examples highlight why on-premise solutions remain dominant, particularly in regions that prioritize data sovereignty or operate with limited cloud infrastructure.
Vaccine Management Solution Market- Geographical Insights
North America is expected to hold a sizable share of the global vaccine management solutions market in 2023. The increased need for vaccination campaigns to control the spread of various diseases, such as hepatitis, tuberculosis, human papillomavirus (HPV), and others, is driving regional growth. For instance, according to a study published in March 2023 by the National Centre for Biotechnology Information (NCBI), 8,300 tuberculosis cases were reported in the United States in 2022. Furthermore, an increase in the introduction of vaccine management solutions to support the vaccination process and supply chain management is expected to drive market expansion.
United States Vaccine Management Solution Market- Country Insights
The United States continues to generate significant revenue in the global Vaccine Management Solution Market, owing to rapid advances in vaccine R&D, increased production capacity, and frequent regulatory approvals. The increasing volume of vaccine formulations, particularly influenza and pediatric vaccines, necessitates efficient digital platforms for inventory tracking, distribution, and cold-chain monitoring. For instance, in June 2022, CSL Seqirus completed a USD 156 million expansion of its US facility to improve formulation and fill-finish capabilities for its cell-based influenza vaccines. Furthermore, in October 2021, the FDA approved Seqirus' FLUCELVAX QUADRIVALENT for an extended age range. Such developments increase vaccine output and distribution complexity, hastening the adoption of advanced vaccine management solutions throughout the country.
Vaccine Management Solution Market- Competitive Landscape:
IBM, Oracle Corporation, SAP SE, Infosys Limited, Microsoft Corporation, and Deloitte Touche Tohmatsu Limited are among the market leaders in vaccine management solutions. These businesses use cloud computing, blockchain, and AI-powered analytics to improve vaccine distribution, storage, and tracking efficiency. The use of IoT-enabled cold chain monitoring systems and data-driven inventory management platforms ensures transparency and real-time visibility throughout the vaccine supply chain. Strategic collaborations among technology providers, healthcare organizations, and government agencies are influencing market growth dynamics. As global immunization programmes expand and digital health infrastructures improve, the competitive landscape is characterized by innovation in data security, scalability, and interoperability to meet the growing demand for efficient and dependable vaccine management solutions.
Recent Developments:
In May 2024, Novavax and Sanofi entered into a co-exclusive licensing agreement to jointly commercialize a COVID-19 vaccine and collaborate on the development of novel COVID-19 and influenza vaccine combinations.
In April 2023, Pfizer disclosed results from phase 3 trials of its RSV vaccines. The study of adult patients found that the vaccine was 67% more effective in preventing infections with two associated symptoms and 86% effective in cases of severe disease.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as following:
GLOBAL VACCINE MANAGEMENT SOLUTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- IBM Corporation
- Siemens Healthineers
- Accenture
- SAP SE
- Oracle Corporation
- Infosys Limited
- SoftClinic
- Logistimo Technologies
- OmniSYS
- VaxCare Digital Health
- Helix Software
- Blue Vector
- Andor Health
- STChealth
- eHealth Africa
- Others
GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Supply Chain Management
- Inventory Management
- Administration and Record Management
- Outcome Monitoring
- Organizational Support
- Patient Registration and Scheduling
- Others
GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Platform Solutions
- One Point Solutions
GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY SOLUTION TYPE- MARKET ANALYSIS, 2019 - 2032
- On-premise
- Cloud-based
- Hybrid
GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY DEPLOYMENT MODE- MARKET ANALYSIS, 2019 - 2032
- SaaS
- IaaS
- PaaS
- Self-hosted
GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Clinics
- Government Facilities
- Corporate Organizations
- Others
GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019 - 2032
- Live vaccines
- Inactivated vaccines
- Conjugate vaccines
- Toxoid vaccines
- Subunit vaccines
GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Vaccine Management Solution Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Vaccine Management Solution Market Snippet by Application
- 2.1.2. Vaccine Management Solution Market Snippet by Type
- 2.1.3. Vaccine Management Solution Market Snippet by Solution Type
- 2.1.4. Vaccine Management Solution Market Snippet by Deployment mode
- 2.1.5. Vaccine Management Solution Market Snippet by End-user
- 2.1.6. Vaccine Management Solution Market Snippet by Vaccine Type
- 2.1.7. Vaccine Management Solution Market Snippet by Country
- 2.1.8. Vaccine Management Solution Market Snippet by Region
- 2.2. Competitive Insights
3. Vaccine Management Solution Key Market Trends
- 3.1. Vaccine Management Solution Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Vaccine Management Solution Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Vaccine Management Solution Market Opportunities
- 3.4. Vaccine Management Solution Market Future Trends
4. Vaccine Management Solution Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Vaccine Management Solution Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Vaccine Management Solution Market Landscape
- 6.1. Vaccine Management Solution Market Share Analysis, 2024
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Vaccine Management Solution Market - By Application
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 7.1.2. Supply Chain Management
- 7.1.3. Inventory Management
- 7.1.4. Administration and Record Management
- 7.1.5. Outcome Monitoring
- 7.1.6. Organizational Support
- 7.1.7. Patient Registration and Scheduling
- 7.1.8. Others
8. Vaccine Management Solution Market - By Type
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
- 8.1.2. Platform Solutions
- 8.1.3. One Point Solutions
9. Vaccine Management Solution Market - By Solution Type
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Solution Type, 2024 & 2032 (%)
- 9.1.2. On-premise
- 9.1.3. Cloud-based
- 9.1.4. Hybrid
10. Vaccine Management Solution Market - By Deployment mode
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Deployment mode, 2024 & 2032 (%)
- 10.1.2. SaaS
- 10.1.3. IaaS
- 10.1.4. PaaS
- 10.1.5. Self-hosted
11. Vaccine Management Solution Market - By End-user
- 11.1. Overview
- 11.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
- 11.1.2. Hospitals & Clinics
- 11.1.3. Government Facilities
- 11.1.4. Corporate Organizations
- 11.1.5. Others
12. Vaccine Management Solution Market - By Vaccine Type
- 12.1. Overview
- 12.1.1. Segment Share Analysis, By Vaccine Type, 2024 & 2032 (%)
- 12.1.2. Live vaccines
- 12.1.3. Inactivated vaccines
- 12.1.4. Conjugate vaccines
- 12.1.5. Toxoid vaccines
- 12.1.6. Subunit vaccines
13. Vaccine Management Solution Market- By Geography
- 13.1. Introduction
- 13.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
- 13.2. North America
- 13.2.1. Overview
- 13.2.2. Vaccine Management Solution Key Manufacturers in North America
- 13.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 13.2.4. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.2.6. North America Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.2.7. North America Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.2.8. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.2.9. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.2.10. U.S.
- 13.2.10.1. Overview
- 13.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.2.10.3. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.2.10.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.2.10.5. U.S. Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.2.10.6. U.S. Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.2.10.7. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.2.10.8. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.2.11. Canada
- 13.2.11.1. Overview
- 13.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.2.11.3. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.2.11.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.2.11.5. Canada Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.2.11.6. Canada Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.2.11.7. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.2.11.8. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.3. Europe
- 13.3.1. Overview
- 13.3.2. Vaccine Management Solution Key Manufacturers in Europe
- 13.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 13.3.4. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.3.6. Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.3.7. Europe Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.3.8. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.3.9. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.3.10. Germany
- 13.3.10.1. Overview
- 13.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.10.3. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.10.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.3.10.5. Germany Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.3.10.6. Germany Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.3.10.7. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.3.10.8. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.3.11. UK
- 13.3.11.1. Overview
- 13.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.11.3. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.11.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.3.11.5. UK Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.3.11.6. UK Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.3.11.7. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.3.11.8. UK Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.3.12. France
- 13.3.12.1. Overview
- 13.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.12.3. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.12.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.3.12.5. France Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.3.12.6. France Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.3.12.7. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.3.12.8. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.3.13. Italy
- 13.3.13.1. Overview
- 13.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.13.3. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.13.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.3.13.5. Italy Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.3.13.6. Italy Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.3.13.7. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.3.13.8. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.3.14. Spain
- 13.3.14.1. Overview
- 13.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.14.3. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.14.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.3.14.5. Spain Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.3.14.6. Spain Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.3.14.7. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.3.14.8. Spain Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.3.15. The Netherlands
- 13.3.15.1. Overview
- 13.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.15.3. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.15.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.3.15.5. The Netherlands Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.3.15.6. The Netherlands Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.3.15.7. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.3.15.8. The Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.3.16. Sweden
- 13.3.16.1. Overview
- 13.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.16.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.16.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.3.16.5. Sweden Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.3.16.6. Sweden Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.3.16.7. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.3.16.8. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.3.17. Russia
- 13.3.17.1. Overview
- 13.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.17.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.17.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.3.17.5. Russia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.3.17.6. Russia Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.3.17.7. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.3.17.8. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.3.18. Poland
- 13.3.18.1. Overview
- 13.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.18.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.18.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.3.18.5. Poland Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.3.18.6. Poland Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.3.18.7. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.3.18.8. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.3.19. Rest of Europe
- 13.3.19.1. Overview
- 13.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.19.3. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.19.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.3.19.5. Rest of the Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.3.19.6. Rest of the Europe Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.3.19.7. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.3.19.8. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.4. Asia Pacific (APAC)
- 13.4.1. Overview
- 13.4.2. Vaccine Management Solution Key Manufacturers in Asia Pacific
- 13.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 13.4.4. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.4.6. APAC Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.4.7. APAC Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.4.8. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.4.9. APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.4.10. China
- 13.4.10.1. Overview
- 13.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.10.3. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.10.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.4.10.5. China Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.4.10.6. China Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.4.10.7. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.4.10.8. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.4.11. India
- 13.4.11.1. Overview
- 13.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.11.3. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.11.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.4.11.5. India Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.4.11.6. India Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.4.11.7. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.4.11.8. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.4.12. Japan
- 13.4.12.1. Overview
- 13.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.12.3. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.12.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.4.12.5. Japan Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.4.12.6. Japan Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.4.12.7. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.4.12.8. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.4.13. South Korea
- 13.4.13.1. Overview
- 13.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.13.3. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.13.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.4.13.5. South Korea Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.4.13.6. South Korea Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.4.13.7. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.4.13.8. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.4.14. Australia
- 13.4.14.1. Overview
- 13.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.14.3. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.14.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.4.14.5. Australia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.4.14.6. Australia Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.4.14.7. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.4.14.8. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.4.15. Indonesia
- 13.4.15.1. Overview
- 13.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.15.3. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.15.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.4.15.5. Indonesia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.4.15.6. Indonesia Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.4.15.7. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.4.15.8. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.4.16. Thailand
- 13.4.16.1. Overview
- 13.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.16.3. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.16.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.4.16.5. Thailand Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.4.16.6. Thailand Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.4.16.7. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.4.16.8. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.4.17. Philippines
- 13.4.17.1. Overview
- 13.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.17.3. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.17.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.4.17.5. Philippines Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.4.17.6. Philippines Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.4.17.7. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.4.17.8. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.4.18. Rest of APAC
- 13.4.18.1. Overview
- 13.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.18.3. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.18.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.4.18.5. Rest of APAC Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.4.18.6. Rest of APAC Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.4.18.7. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.4.18.8. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.5. Latin America (LATAM)
- 13.5.1. Overview
- 13.5.2. Vaccine Management Solution Key Manufacturers in Latin America
- 13.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 13.5.4. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.5.6. LATAM Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.5.7. LATAM Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.5.8. LATAM Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.5.9. LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.5.10. Brazil
- 13.5.10.1. Overview
- 13.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.5.10.3. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.5.10.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.5.10.5. Brazil Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.5.10.6. Brazil Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.5.10.7. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.5.10.8. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.5.11. Mexico
- 13.5.11.1. Overview
- 13.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.5.11.3. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.5.11.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.5.11.5. Mexico Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.5.11.6. Mexico Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.5.11.7. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.5.11.8. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.5.12. Argentina
- 13.5.12.1. Overview
- 13.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.5.12.3. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.5.12.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.5.12.5. Argentina Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.5.12.6. Argentina Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.5.12.7. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.5.12.8. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.5.13. Colombia
- 13.5.13.1. Overview
- 13.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.5.13.3. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.5.13.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.5.13.5. Colombia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.5.13.6. Colombia Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.5.13.7. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.5.13.8. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.5.14. Rest of LATAM
- 13.5.14.1. Overview
- 13.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.5.14.3. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.5.14.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.5.14.5. Rest of LATAM Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.5.14.6. Rest of LATAM Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.5.14.7. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.5.14.8. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.6. Middle East and Africa
- 13.6.1. Overview
- 13.6.2. Vaccine Management Solution Key Manufacturers in Middle East and Africa
- 13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 13.6.4. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.6.6. Middle East and Africa Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.6.7. Middle East and Africa Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.6.8. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.6.9. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.6.10. Saudi Arabia
- 13.6.10.1. Overview
- 13.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.6.10.3. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.6.10.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.6.10.5. Saudi Arabia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.6.10.6. Saudi Arabia Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.6.10.7. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.6.10.8. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.6.11. United Arab Emirates
- 13.6.11.1. Overview
- 13.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.6.11.3. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.6.11.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.6.11.5. United Arab Emirates Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.6.11.6. United Arab Emirates Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.6.11.7. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.6.11.8. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.6.12. Israel
- 13.6.12.1. Overview
- 13.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.6.12.3. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.6.12.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.6.12.5. Israel Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.6.12.6. Israel Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.6.12.7. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.6.12.8. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.6.13. Turkey
- 13.6.13.1. Overview
- 13.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.6.13.3. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.6.13.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.6.13.5. Turkey Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.6.13.6. Turkey Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.6.13.7. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.6.13.8. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.6.14. Algeria
- 13.6.14.1. Overview
- 13.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.6.14.3. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.6.14.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.6.14.5. Algeria Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.6.14.6. Algeria Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.6.14.7. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.6.14.8. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.6.15. Egypt
- 13.6.15.1. Overview
- 13.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.6.15.3. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.6.15.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.6.15.5. Egypt Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.6.15.6. Egypt Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.6.15.7. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.6.15.8. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 13.6.16. Rest of MEA
- 13.6.16.1. Overview
- 13.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.6.16.3. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.6.16.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 13.6.16.5. Rest of MEA Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
- 13.6.16.6. Rest of MEA Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
- 13.6.16.7. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 13.6.16.8. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
14. Key Vendor Analysis- Vaccine Management Solution Industry
- 14.1. Competitive Benchmarking
- 14.1.1. Competitive Dashboard
- 14.1.2. Competitive Positioning
- 14.2. Company Profiles
- 14.2.1. IBM Corporation
- 14.2.2. Siemens Healthineers
- 14.2.3. Accenture
- 14.2.4. SAP SE
- 14.2.5. Oracle Corporation
- 14.2.6. Infosys Limited
- 14.2.7. SoftClinic
- 14.2.8. Logistimo Technologies
- 14.2.9. OmniSYS
- 14.2.10. VaxCare Digital Health
- 14.2.11. Helix Software
- 14.2.12. Blue Vector
- 14.2.13. Andor Health
- 14.2.14. STChealth
- 14.2.15. eHealth Africa
- 14.2.16. Others
15. 360 Degree Analyst View
16. Appendix
- 16.1. Research Methodology
- 16.2. References
- 16.3. Abbreviations
- 16.4. Disclaimer
- 16.5. Contact Us
